Three new studies–one,, a pharmaco-genetic study, is groundbreaking–confirm that widely prescribed psychotropic drugs that pose serious risks of harm, offer no therapeutic benefit.

 

Read More

The catalyst for Dr. Elliott’s article was the tragic case of Dan Markingson, a 26-year old who committed suicide in May 2004, while enrolled in the CAFE trial, prescribed Seroquel. This case encapsulates the tragic consequences of a broken system which is not designed to detect the hazards for human subjects posed by market-driven research.

Read More

What’s in a Warning? Antidepressants and Risk of Suicide – FindLaw Thu, 22 Apr 2004 Contrary to the published reports in the peer-reviewed journals, the preponderance of evidence demonstrates that antidepressants pose a greater risk than a benefit for children. *[References below] Informed medical treatment decisions hinge on the decision maker having all the relevant…

Read More

FDA to review “missing” drug company documents Fri, 31 Dec 2004 Related Link: Peter Breggin, MD RE: Eli Lilly’s Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance In the final hours of 2004, an investigative reporter for the British Medical Journal obtained long “missing” Eli Lilly company documents, suggesting “a…

Read More